24 апр. 2023 г. · Amantadine is an antiviral agent with mild antiparkinsonian activity. Amantadine was used in the early 2000s for Influenza A treatment.

Evidence from randomised controlled trials over the past 5 years has confirmed the efficacy of amantadine to treat levodopa-induced dyskinesias in patients with ...

Amantadine, originally used as an antiviral drug, has been shown to improve the symptoms of Parkinson's disease.

Amantadine is a drug with diverse uses ranging from prevention of influenza A illness to the treatment of patients with Parkinson's disease.

Amantadine, a well-tolerated and modestly effective antiparkinsonian agent, was recently found to possess NMDA antagonistic properties.

3 апр. 2012 г. · Amantadine was originally introduced and utilized as an antiviral medication. A single patient noticed relief in her Parkinson disease (PD) symptoms after ...

Amantadine use was an independent predictor of improved survival (p < 0.01). Improved survival was also associated with a higher 10-year expected survival.

23 февр. 2021 г. · The aim of the current review was to provide a new, in-depth insight into possible pharmacological targets of amantadine to pave the way to extending its ...

4 апр. 2022 г. · This clinical trial will assess the efficacy and safety of amantadine in the prevention of COVID-19 progression toward acute respiratory failure and ...

Amantadine appears effective in the long-term treatment of some patients with Parkinson's disease.